{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:05:02Z","timestamp":1779271502977,"version":"3.51.4"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.tranon.2025.102493","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T06:25:42Z","timestamp":1754634342000},"page":"102493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Diversity and inclusivity in oncology: A narrative review and orientation for institutional measures in Germany"],"prefix":"10.1016","volume":"60","author":[{"given":"Hendrik","family":"Dapper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3856-3864","authenticated-orcid":false,"given":"Sabine","family":"Oertelt-Prigione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertraud","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8362-5202","authenticated-orcid":false,"given":"Nina","family":"Weishaupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Quaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Romotzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1427-151X","authenticated-orcid":false,"given":"Lena","family":"Haarmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Fokas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Linde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"G\u00f6rner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3210-0474","authenticated-orcid":false,"given":"Laura","family":"Wortmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0001","first-page":"247","article-title":"The importance of diversity and inclusion in the healthcare workforce","volume":"112","author":"Stanford","year":"2020","journal-title":"J. Natl. Med. Assoc."},{"issue":"40","key":"10.1016\/j.tranon.2025.102493_bib0002","doi-asserted-by":"crossref","first-page":"12240","DOI":"10.1073\/pnas.1515612112","article-title":"National Institutes of Health addresses the science of diversity","volume":"112","author":"Valantine","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"19","key":"10.1016\/j.tranon.2025.102493_bib0003","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.3390\/cancers16193338","article-title":"Meta-analysis of age, sex, and race disparities in the era of contemporary urothelial carcinoma treatment","volume":"16","author":"Barsouk","year":"2024","journal-title":"Cancers. (Basel)"},{"issue":"2","key":"10.1016\/j.tranon.2025.102493_bib0004","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3322\/caac.21757","article-title":"Cancer statistics for A merican I ndian and A laska N ative individuals, 2022: including increasing disparities in early onset colorectal cancer. CA: a","volume":"73","author":"Kratzer","year":"2023","journal-title":"Cancer J. Clin."},{"issue":"10250","key":"10.1016\/j.tranon.2025.102493_bib0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.tranon.2025.102493_bib0006","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/jnci\/djac092","article-title":"An evaluation of sex- and gender-based analyses in oncology clinical trials","volume":"114","author":"Hall","year":"2022","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"Supplement_2","key":"10.1016\/j.tranon.2025.102493_bib0007","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/infdis\/jiz174","article-title":"The science and value of diversity: closing the gaps in our understanding of inclusion and diversity","volume":"220","author":"Swartz","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tranon.2025.102493_bib0008","series-title":"Diversity","author":"Griffin","year":"2017"},{"key":"10.1016\/j.tranon.2025.102493_bib0009","series-title":"Heterogeneity","author":"Park","year":"2017"},{"issue":"9","key":"10.1016\/j.tranon.2025.102493_bib0010","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1007\/s00247-022-05356-0","article-title":"What is diversity?","volume":"52","author":"Servaes","year":"2022","journal-title":"Pediatr. Radiol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0011","article-title":"Demarginalizing the intersection of race and sex: a black feminist critique of antidiscrimination doctrine, feminist theory and antiracist politics","volume":"1989","author":"Crenshaw","year":"2015","journal-title":"Univ. Chic. Leg. Forum"},{"key":"10.1016\/j.tranon.2025.102493_bib0012","doi-asserted-by":"crossref","unstructured":"Schneider J.S., Vincent M.B. Silenzio, Laura Erickson-Schroth. The Glma Handbook On Lgbt Health. Santa Barbara; 2019.","DOI":"10.5040\/9798216969457"},{"issue":"8","key":"10.1016\/j.tranon.2025.102493_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005968","article-title":"Delayed care and mortality among women and men with myocardial infarction","volume":"6","author":"Bugiardini","year":"2017","journal-title":"J. Am. Heart. Assoc."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0014","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/bja\/aet127","article-title":"Sex differences in pain: a brief review of clinical and experimental findings","volume":"111","author":"Bartley","year":"2013","journal-title":"Br. J. Anaesth."},{"issue":"2","key":"10.1016\/j.tranon.2025.102493_bib0015","first-page":"11","article-title":"Biologische und psychosoziale einflussfaktoren auf geschlechterbezogene unterschiede beim Schmerz","volume":"7","author":"Icenhour","year":"2015","journal-title":"GEND. \u2013 Z. Geschlecht Kult. Ges."},{"key":"10.1016\/j.tranon.2025.102493_bib0016","series-title":"Krebs in Deutschland f\u00fcr 2017\/2018","author":"Erdmann","year":"2021"},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0017","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a","volume":"71","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.tranon.2025.102493_bib0018","first-page":"363","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2025.102493_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102864","article-title":"Health inequalities in cancer care: a literature review of pathways to diagnosis in the United Kingdom","volume":"76","author":"Scott","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.tranon.2025.102493_bib0020","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/pon.5890","article-title":"Intersectionality in cancer care: a systematic review of current research and future directions","volume":"31","author":"Kelly-Brown","year":"2022","journal-title":"Psychooncology."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0021","doi-asserted-by":"crossref","first-page":"9993","DOI":"10.1038\/s41467-024-54444-2","article-title":"An umbrella review of socioeconomic status and cancer","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0022","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-021-00316-8","article-title":"Improving diversity in medical research","volume":"7","author":"Sharma","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"6","key":"10.1016\/j.tranon.2025.102493_bib0023","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11904-022-00629-7","article-title":"Transgender individuals and digital health","volume":"19","author":"Radix","year":"2022","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"6004","key":"10.1016\/j.tranon.2025.102493_bib0024","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1126\/science.1193147","article-title":"Evidence for a collective intelligence factor in the performance of human groups","volume":"330","author":"Woolley","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.tranon.2025.102493_bib0025","unstructured":"Klaus L\u00fcbner, Data Privacy Made in Germany, Translation: Eric RosencrantzCopyright: Goethe-Institute, V., Internet-RedaktionNovember (2014). Available from: https:\/\/www.goethe.de\/ins\/id\/en\/kul\/mte\/opd\/20446236.html."},{"key":"10.1016\/j.tranon.2025.102493_bib0026","series-title":"Data collection on equality, discrimination and antigypsyism","author":"Reuss","year":"2022"},{"key":"10.1016\/j.tranon.2025.102493_bib0027","series-title":"Die Restlose Erfassung: Volksz\u00e4hlen, Identifizieren, Aussondern im Nationalsozialismus","author":"Aly","year":"2019"},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0028","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2307\/2808153","article-title":"Population statistics, the Holocaust, and the Nuremberg Trials","volume":"24","author":"Seltzer","year":"1998","journal-title":"Popul. Dev. Rev."},{"key":"10.1016\/j.tranon.2025.102493_bib0029","series-title":"Die DDR Im Blick der Stasi 1954: Die geheimen Berichte an Die SED-F\u00fchrung","year":"2024"},{"key":"10.1016\/j.tranon.2025.102493_bib0030","series-title":"Bundeszentrale f\u00fcr Politische Bildung","article-title":"Umgang mit Minderheiten in der DDR","author":"Rother","year":"2012"},{"key":"10.1016\/j.tranon.2025.102493_bib0031","series-title":"Geschichte antirassistischer Bewegungen in der Bundesrepublik Deutschland nach 1945","author":"Schmelzer","year":"2023"},{"key":"10.1016\/j.tranon.2025.102493_bib0032","series-title":"The Guest Worker Question in Postwar Germany","author":"Chin","year":"2009"},{"key":"10.1016\/j.tranon.2025.102493_bib0033","series-title":"Annual Meeting","first-page":"e622","article-title":"Clinical oncology practice 2015: preparing for the future. American Society of Clinical Oncology educational book","author":"Kosty","year":"2015"},{"issue":"13","key":"10.1016\/j.tranon.2025.102493_bib0034","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.21.02377","article-title":"Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials","volume":"40","author":"Unger","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0035","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1038\/s41467-024-46945-x","article-title":"Outcome differences by sex in oncology clinical trials","volume":"15","author":"Kammula","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.tranon.2025.102493_bib0036","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2018.1080","article-title":"Association of patient sex with chemotherapy-related toxic effects: a retrospective analysis of the PETACC-3 trial conducted by the EORTC Gastrointestinal Group","volume":"4","author":"Cristina","year":"2018","journal-title":"JAMa Oncol."},{"issue":"31","key":"10.1016\/j.tranon.2025.102493_bib0037","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1200\/JCO.2005.205.60","article-title":"Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group","volume":"23","author":"Klimm","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2025.102493_bib0038","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.2005.03.171","article-title":"Influence of sex on toxicity and treatment outcome in small-cell lung cancer","volume":"23","author":"Singh","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0039","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.tranon.2025.102493_bib0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00280-012-2018-4","article-title":"Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study","volume":"71","author":"Mueller","year":"2013","journal-title":"Cancer Chemother Pharmacol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0041","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjh.14860","article-title":"Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients","volume":"179","author":"Pfreundschuh","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.tranon.2025.102493_bib0042","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/clpt.2014.12","article-title":"Conventional dosing of anticancer agents: precisely wrong or just inaccurate?","volume":"95","author":"Bins","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.tranon.2025.102493_bib0043","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1200\/JCO.1996.14.9.2590","article-title":"Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative","volume":"14","author":"Gurney","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2025.102493_bib0044","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/annonc\/mdz414","article-title":"Gender medicine and oncology: report and consensus of an ESMO workshop","volume":"30","author":"Wagner","year":"2019","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2025.102493_bib0064","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.20.02602","article-title":"Persistent disparity: socioeconomic deprivation and cancer outcomes in patients treated in clinical trials","volume":"39","author":"Unger","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102493_bib0065","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkad058","article-title":"Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022","volume":"7","author":"Guadamuz","year":"2023","journal-title":"JNCI. Cancer Spectr."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0066","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1186\/s12889-017-4692-y","article-title":"Cancer survival disparities worsening by socio-economic disadvantage over the last 3 decades in new South Wales, Australia","volume":"17","author":"Tervonen","year":"2017","journal-title":"BMC. Public Health"},{"issue":"2","key":"10.1016\/j.tranon.2025.102493_bib0067","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1245\/s10434-019-07922-7","article-title":"Size and importance of socioeconomic status-based disparities in use of surgery in nonadvanced stage gastrointestinal cancers","volume":"27","author":"Swords","year":"2020","journal-title":"Ann. Surg. Oncol."},{"issue":"13","key":"10.1016\/j.tranon.2025.102493_bib0080","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.21.02377","article-title":"Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials","volume":"40","author":"Unger","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102493_bib0081","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1470-2045(18)30261-4","article-title":"Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis","volume":"19","author":"Conforti","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tranon.2025.102493_bib0082","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.786046","article-title":"Impact of patient age on clinical efficacy and toxicity of checkpoint inhibitor therapy","volume":"12","author":"Wong","year":"2021","journal-title":"Front, Immunol"},{"issue":"11","key":"10.1016\/j.tranon.2025.102493_bib0056","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.4158","article-title":"Geriatric assessment-driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial","volume":"7","author":"Li","year":"2021","journal-title":"JAMa Oncol."},{"key":"10.1016\/j.tranon.2025.102493_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114181","article-title":"Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials","volume":"207","author":"Nicol\u00f2","year":"2024","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.tranon.2025.102493_bib0084","doi-asserted-by":"crossref","first-page":"e1516","DOI":"10.1634\/theoncologist.2019-0701","article-title":"Predicting chemotherapy toxicity in older patients with cancer: a multicenter prospective study","volume":"25","author":"Feliu","year":"2020","journal-title":"Oncologist."},{"key":"10.1016\/j.tranon.2025.102493_bib0045","unstructured":"National Cancer Institute. Risk factors: age - NCI; 2021; Available from: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/age."},{"issue":"38","key":"10.1016\/j.tranon.2025.102493_bib0046","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/EDBK_201435","article-title":"Immunotherapy in older adults with advanced cancers: implications for clinical decision-making and future research","author":"Kanesvaran","year":"2018","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"12","key":"10.1016\/j.tranon.2025.102493_bib0047","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1001\/jamaoncol.2022.5020","article-title":"Clinical trial participation among older adult Medicare fee-for-service beneficiaries with cancer","volume":"8","author":"Green","year":"2022","journal-title":"JAMa Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100468","article-title":"Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study","volume":"7","author":"Baldini","year":"2022","journal-title":"ESMo Open."},{"issue":"10","key":"10.1016\/j.tranon.2025.102493_bib0049","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1016\/S2666-7568(21)00179-3","article-title":"Is cancer biology different in older patients?","volume":"2","author":"van Herck","year":"2021","journal-title":"Lancet Healthy Longev."},{"issue":"12","key":"10.1016\/j.tranon.2025.102493_bib0050","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.6004\/jnccn.2013.0176","article-title":"Determining chemotherapy tolerance in older patients with cancer","volume":"11","author":"Kim","year":"2013","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"4","key":"10.1016\/j.tranon.2025.102493_bib0051","article-title":"Correlation between patients' age and cancer immunotherapy efficacy","volume":"8","author":"Wu","year":"2019","journal-title":"Oncoimmunology."},{"issue":"11","key":"10.1016\/j.tranon.2025.102493_bib0052","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1200\/JCO.2012.42.9894","article-title":"Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients","volume":"31","author":"Aparicio","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"25","key":"10.1016\/j.tranon.2025.102493_bib0053","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.tranon.2025.102493_bib0054","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1200\/JCO.2007.10.6559","article-title":"Comprehensive geriatric assessment for older patients with cancer","volume":"25","author":"Extermann","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102493_bib0055","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jgo.2019.04.016","article-title":"A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer","volume":"10","author":"van Walree","year":"2019","journal-title":"J. Geriatr. Oncol."},{"issue":"18","key":"10.1016\/j.tranon.2025.102493_bib0057","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1200\/JCO.2012.44.5031","article-title":"Sex is an independent prognostic indicator for survival and relapse\/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials","volume":"31","author":"Joosse","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102493_bib0058","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc.2016.30","article-title":"Sexual dimorphism in cancer","volume":"16","author":"Clocchiatti","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"19","key":"10.1016\/j.tranon.2025.102493_bib0059","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1002\/cncr.34390","article-title":"Sex disparities in the incidence of 21 cancer types: quantification of the contribution of risk factors","volume":"128","author":"Jackson","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.tranon.2025.102493_bib0060","series-title":"Cancer Stat Facts: Cancer Disparities: Rates of New Cases By Race\/Ethnicity","article-title":"epidemiology, and end result program","year":"2025"},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0061","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41391-021-00451-z","article-title":"Racial disparities in prostate cancer among black men: epidemiology and outcomes","volume":"25","author":"Chowdhury-Paulino","year":"2022","journal-title":"Prostate Cancer Prostatic. Dis."},{"issue":"9","key":"10.1016\/j.tranon.2025.102493_bib0062","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030387","article-title":"Prostate cancer disparities by race and ethnicity: from nucleotide to neighborhood","volume":"8","author":"Rebbeck","year":"2018","journal-title":"Cold. Spring. Harb. Perspect. Med."},{"issue":"10","key":"10.1016\/j.tranon.2025.102493_bib0063","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/ijc.34662","article-title":"Trends in cancer incidence by socioeconomic deprivation in Germany in 2007 to 2018: an ecological registry-based study","volume":"153","author":"Jansen","year":"2023","journal-title":"Int. j. cancer"},{"issue":"4","key":"10.1016\/j.tranon.2025.102493_bib0068","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.amepre.2013.11.010","article-title":"Health inequalities among sexual minority adults: evidence from ten U.S. states, 2010","volume":"46","author":"Blosnich","year":"2014","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.tranon.2025.102493_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2020.104245","article-title":"Using sexual orientation and gender identity data in electronic health records to assess for disparities in preventive health screening services","volume":"142","author":"Grasso","year":"2020","journal-title":"Int J Med Inf."},{"issue":"2","key":"10.1016\/j.tranon.2025.102493_bib0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/lgbt.2013.0022","article-title":"Disparities in health risk behavior and psychological distress among Gay versus heterosexual male cancer survivors","volume":"1","author":"Kamen","year":"2014","journal-title":"LGBT. Health"},{"issue":"2","key":"10.1016\/j.tranon.2025.102493_bib0071","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annepidem.2017.12.001","article-title":"Sexual orientation measurement and chronic disease disparities: national Health and Nutrition Examination Survey, 2009-2014","volume":"28","author":"Patterson","year":"2018","journal-title":"Ann. Epidemiol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0072","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/lgbt.2013.0033","article-title":"Health conditions in younger, middle, and older ages: are there differences by sexual orientation?","volume":"1","author":"Boehmer","year":"2014","journal-title":"LGBT. Health"},{"issue":"2","key":"10.1016\/j.tranon.2025.102493_bib0073","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/26895269.2022.2155289","article-title":"Culturally safe, appropriate, and high-quality breast cancer screening for transgender people: a scoping review","volume":"24","author":"Ramsey","year":"2023","journal-title":"Int. J. Transgend. Health"},{"key":"10.1016\/j.tranon.2025.102493_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.763348","article-title":"I need more knowledge\": qualitative analysis of oncology providers' experiences with sexual and gender minority patients","volume":"13","author":"Tamargo","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.tranon.2025.102493_bib0075","article-title":"Sexual health in women and sexual-gender-minority patients with cancer: a nationwide survey on healthcare professional awareness and attitude on behalf of MITO and AIRO-gynecology group","volume":"43","author":"Barcellini","year":"2024","journal-title":"J. Cancer Policy"},{"key":"10.1016\/j.tranon.2025.102493_bib0076","year":"2006","journal-title":"Communication in Cancer Care"},{"issue":"2","key":"10.1016\/j.tranon.2025.102493_bib0077","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/annonc\/mdp564","article-title":"Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009","volume":"21","author":"Stiefel","year":"2010","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0078","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1188\/16.ONF.E24-E33","article-title":"Cross-Cultural communication in oncology: challenges and training interests","author":"Weber","year":"2016","journal-title":"Oncol. Nurs. Forum."},{"key":"10.1016\/j.tranon.2025.102493_bib0079","series-title":"Partizipative Forschung und Gender: Emanzipatorische Forschungsans\u00e4tze Weiterdenken","year":"2020"},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0085","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0086","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s12885-019-5970-0","article-title":"Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines","volume":"19","author":"Dapper","year":"2019","journal-title":"BMC. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0087","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24362-8","article-title":"Influence of radiation treatment technique (IMRT vs. 3D-RT) on acute toxicity and prognostic factors for survival for anal cancer","volume":"12","author":"Sauter","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0088","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13014-018-1187-7","article-title":"Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer","volume":"13","author":"Dapper","year":"2018","journal-title":"Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2025.102493_bib0089","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1470-2045(20)30013-9","article-title":"Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial","volume":"21","author":"Nestle","year":"2020","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2025.102493_bib0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(20)30601-X","article-title":"PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Borchmann","year":"2021","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0091","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","article-title":"Quantitative Analyses of normal tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues","volume":"76","author":"Bentzen","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0092","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","article-title":"UK consensus on normal tissue dose constraints for stereotactic radiotherapy","volume":"30","author":"Hanna","year":"2018","journal-title":"Clin. Oncol. (R. Coll. Radiol)"},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0093","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2010.09.030","article-title":"Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy","volume":"82","author":"Kachnic","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.tranon.2025.102493_bib0094","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9100135","article-title":"Can intensity-modulated-radiotherapy reduce toxicity in head and neck squamous cell carcinoma?","volume":"9","author":"van der Veen","year":"2017","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.tranon.2025.102493_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109576","article-title":"Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? A secondary analysis of the population-based phase II SABR-5 trial","volume":"182","author":"Eufemon Cereno","year":"2023","journal-title":"Radiother. oncol. j. Eur. Soc. Ther. Radiol. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102493_bib0096","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clon.2022.02.010","article-title":"UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy","volume":"34","author":"Diez","year":"2022","journal-title":"Clin. Oncol. (R. Coll. Radiol)"},{"issue":"4","key":"10.1016\/j.tranon.2025.102493_bib0097","first-page":"1377","article-title":"Gender-specific quality of life after cancer in young adulthood: a comparison with the general population. Quality of life research an international journal of quality of life aspects of treatment","volume":"23","author":"Geue","year":"2014","journal-title":"Care Rehabil."},{"issue":"8","key":"10.1016\/j.tranon.2025.102493_bib0098","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.21037\/jtd-20-1054","article-title":"Gender effects on quality of life and symptom burden in patients with lung cancer: results from a prospective, cross-cultural, multi-center study","volume":"12","author":"Koch","year":"2020","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0099","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1746-160X-6-21","article-title":"Gender specific quality of life in patients with oral squamous cell carcinomas","volume":"6","author":"Maciejewski","year":"2010","journal-title":"Head. Face Med."},{"key":"10.1016\/j.tranon.2025.102493_bib0100","article-title":"Gender-dependent radiotherapy: the next step in personalised medicine?","volume":"147","author":"de","year":"2020"},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0101","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/0020731419885093","article-title":"A systematic review of the discrimination against sexual and Gender minority in health care settings","volume":"50","author":"Ayhan","year":"2020","journal-title":"Int. J. Health Serv. Plan. Adm. Eval."},{"issue":"32","key":"10.1016\/j.tranon.2025.102493_bib0102","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1200\/JCO.2017.72.5465","article-title":"Associations between sexual orientation and overall and site-specific diagnosis of cancer: evidence from two national patient surveys in England","volume":"35","author":"Saunders","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.tranon.2025.102493_bib0103","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/ijc.34850","article-title":"International Anal Neoplasia Society's consensus guidelines for anal cancer screening","volume":"154","author":"Stier","year":"2024","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0104","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother. oncol. j. Eur. Soc. Ther. Radiol. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2013.12.027","article-title":"Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer","volume":"89","author":"Beitler","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9388","key":"10.1016\/j.tranon.2025.102493_bib0106","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0107","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/jnci\/87.3.198","article-title":"Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer","volume":"87","author":"Sause","year":"1995","journal-title":"J. Natl, Cancer Inst"},{"issue":"11","key":"10.1016\/j.tranon.2025.102493_bib0108","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-course radiation plus temozolomide in elderly patients with glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N. Engl, J. Med."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0109","doi-asserted-by":"crossref","first-page":"899","DOI":"10.21037\/apm-20-1206","article-title":"Update on the management of elderly patients with glioblastoma: a narrative review","volume":"10","author":"Ironside","year":"2021","journal-title":"Ann. Palliat. Med."},{"issue":"24","key":"10.1016\/j.tranon.2025.102493_bib0110","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1200\/JCO.2014.55.1168","article-title":"Radiation treatment in older patients: a framework for clinical decision making","volume":"32","author":"Smith","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102493_bib0111","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.outlook.2012.08.008","article-title":"Psychosocial, cultural, and spiritual health disparities in end-of-life and palliative care: where we are and where we need to go","volume":"60","author":"Evans","year":"2012","journal-title":"Nurs. Outlook."},{"issue":"11","key":"10.1016\/j.tranon.2025.102493_bib0112","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/jpm.2013.9468","article-title":"Racial and ethnic disparities in palliative care","volume":"16","author":"Johnson","year":"2013","journal-title":"J. Palliat. Med."},{"key":"10.1016\/j.tranon.2025.102493_bib0113","unstructured":"Gerlach H., Schupp M., Block J., Hagen C., Berner F. Lebenslagen, Partizipation gesundheitlich-\/pfl.-rische Versorg. \u00e4lterer Lesben Schwuler Dtschl. Expert. zum Siebten Altenbericht Bundesregier. Hrsg. von 2016."},{"issue":"6","key":"10.1016\/j.tranon.2025.102493_bib0114","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11920-016-0697-y","article-title":"The mental health of older LGBT adults","volume":"18","author":"Yarns","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.tranon.2025.102493_bib0115","unstructured":"WHO. Palliative Care - the essential facts; 2023."},{"key":"10.1016\/j.tranon.2025.102493_bib0116","doi-asserted-by":"crossref","first-page":"331","DOI":"10.25259\/IJPC_21_21","article-title":"Improving access and health outcomes in palliative care through cultural competence: an exploration of opportunities and challenges in India","volume":"28","author":"Kashyap","year":"2022","journal-title":"Indian J. Palliat. Care"},{"key":"10.1016\/j.tranon.2025.102493_bib0117","unstructured":"Lind L. Addressing health disparities through inclusive clinical research practices 2023. https:\/\/doi.org\/10.37421\/2795-6172.2023.7.203."},{"issue":"10","key":"10.1016\/j.tranon.2025.102493_bib0118","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41562-018-0433-1","article-title":"Making gender diversity work for scientific discovery and innovation","volume":"2","author":"Nielsen","year":"2018","journal-title":"Nat. Hum. Behav."},{"issue":"5","key":"10.1016\/j.tranon.2025.102493_bib0119","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103373","article-title":"Equitable inclusion of diverse populations in oncology clinical trials: deterrents and drivers","volume":"9","author":"Vidal","year":"2024","journal-title":"ESMo Open."},{"key":"10.1016\/j.tranon.2025.102493_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/EDBK_156686","article-title":"The role of clinical trial participation in cancer research: barriers, evidence, and strategies","volume":"36","author":"Unger","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"17","key":"10.1016\/j.tranon.2025.102493_bib0121","doi-asserted-by":"crossref","first-page":"9284","DOI":"10.1073\/pnas.1915378117","article-title":"The diversity-innovation paradox in science","volume":"117","author":"Hofstra","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"18","key":"10.1016\/j.tranon.2025.102493_bib0122","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1002\/cncr.33600","article-title":"Addressing racial\/ethnic disparities in cancer clinical trials: everyone has a role to play","volume":"127","author":"Habr","year":"2021","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0123","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamaoncol.2015.3924","article-title":"Patient income level and cancer clinical trial participation: a prospective survey study","volume":"2","author":"Unger","year":"2016","journal-title":"JAMa Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102493_bib0124","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.urology.2004.10.023","article-title":"Effects of untreated syphilis in the negro male, 1932 to 1972: a closure comes to the Tuskegee study, 2004","volume":"65","author":"Baker","year":"2005","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0125","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1353\/hpu.0.0323","article-title":"More than Tuskegee: understanding mistrust about research participation","volume":"21","author":"Scharff","year":"2010","journal-title":"J. Health Care Poor. Underserved"},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0126","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jamaoncol.2020.7320","article-title":"Association of Race\/ethnicity and the 21-gene recurrence score with breast cancer-specific mortality among US women","volume":"7","author":"Hoskins","year":"2021","journal-title":"JAMa Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0127","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1186\/s13063-021-05849-7","article-title":"Promoting inclusion in clinical trials-a rapid review of the literature and recommendations for action","volume":"22","author":"Bodicoat","year":"2021","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0128","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/cam4.5150","article-title":"Increasing patient participation in oncology clinical trials","volume":"12","author":"Chen","year":"2023","journal-title":"Cancer Med."},{"issue":"9","key":"10.1016\/j.tranon.2025.102493_bib0129","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1200\/JOP.19.00662","article-title":"Barriers to participation in therapeutic clinical trials as perceived by community oncologists","volume":"16","author":"Wong","year":"2020","journal-title":"JCO Oncol Pr."},{"issue":"10","key":"10.1016\/j.tranon.2025.102493_bib0130","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1007\/s00432-022-04559-0","article-title":"Relevance of tumor boards for the inclusion of patients in oncological clinical trials","volume":"149","author":"Dapper","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.tranon.2025.102493_bib0131","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/cncr.33399","article-title":"Use of a clinical trial screening tool to enhance patient accrual","volume":"127","author":"St Germain","year":"2021","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0132","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijrobp.2022.11.044","article-title":"Increasing diversity of patients in radiation oncology clinical trials","volume":"116","author":"Roy","year":"2023","journal-title":"Int. J. Radiat. Oncol.*Biol.*Phys."},{"key":"10.1016\/j.tranon.2025.102493_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2021.100718","article-title":"Sociodemographic diversity in cancer clinical trials: new findings on the effect of race and ethnicity","volume":"21","author":"Meyer","year":"2021","journal-title":"Contemp. Clin. Trials Commun."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0134","article-title":"Inclusive oncological trials and targeted treatments cannot ignore sex and gender","volume":"2","author":"Heinrich","year":"2023","journal-title":"BMJ Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2025.102493_bib0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cncr.33905","article-title":"Strategies to improve diversity, equity, and inclusion in clinical trials","volume":"128","author":"Kahn","year":"2022","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.tranon.2025.102493_bib0136","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1200\/JCO.2012.45.4553","article-title":"Patient income level and cancer clinical trial participation","volume":"31","author":"Unger","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102493_bib0137","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamaoncol.2023.7314","article-title":"Analysis and optimization of equitable US cancer clinical trial center access by travel time","volume":"10","author":"Lee","year":"2024","journal-title":"JAMa Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0138","doi-asserted-by":"crossref","first-page":"e6905","DOI":"10.1002\/cam4.6905","article-title":"Effects of socioeconomic status on enrollment in clinical trials for cancer: a systematic review","volume":"13","author":"Donzo","year":"2024","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.tranon.2025.102493_bib0139","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101610","article-title":"Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study","volume":"8","author":"Charton","year":"2023","journal-title":"ESMo Open"},{"issue":"6","key":"10.1016\/j.tranon.2025.102493_bib0140","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/oncolo\/oyad009","article-title":"Analysis of female participant representation in registered oncology clinical trials in the United States from 2008 to 2020","volume":"28","author":"Perera","year":"2023","journal-title":"Oncologist."},{"issue":"Suppl 4","key":"10.1016\/j.tranon.2025.102493_bib0141","article-title":"Gender and sex disparity in cancer trials","volume":"5","author":"Lee","year":"2020","journal-title":"ESMo Open"},{"key":"10.1016\/j.tranon.2025.102493_bib0142","first-page":"3","article-title":"Enrollment of racial minorities in Clinical trials: old problem assumes new urgency in the age of immunotherapy. American Society of Clinical Oncology educational book","volume":"39","author":"Nazha","year":"2019","journal-title":"Am. Soc. Clin. Oncol., Annu. Meet."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0143","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1186\/s13063-022-07004-2","article-title":"Underrepresentation of women in randomized controlled trials: a systematic review and meta-analysis","volume":"23","author":"Daitch","year":"2022","journal-title":"Trials"},{"issue":"12","key":"10.1016\/j.tranon.2025.102493_bib0144","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/jamaoncol.2019.2055","article-title":"Factors associated with age disparities among cancer clinical trial participants","volume":"5","author":"Ludmir","year":"2019","journal-title":"JAMa Oncol."},{"issue":"7","key":"10.1016\/j.tranon.2025.102493_bib0145","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.annonc.2021.04.003","article-title":"Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020","volume":"32","author":"Haslam","year":"2021","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102493_bib0146","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.12558","article-title":"Assessment of new molecular entities approved for cancer treatment in 2020","volume":"4","author":"Smith","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"20","key":"10.1016\/j.tranon.2025.102493_bib0147","doi-asserted-by":"crossref","first-page":"595","DOI":"10.21037\/atm.2019.05.58","article-title":"Immunotherapy and targeted therapy-the new roadmap in cancer treatment","volume":"7","author":"Shahid","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0148","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0423","article-title":"Estimation of the percentage of US patients with cancer who are eligible for immune checkpoint inhibitor drugs","volume":"3","author":"Haslam","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0149","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1200\/JCO.2015.62.0096","article-title":"Cancer genomics: diversity and disparity across ethnicity and geography","volume":"34","author":"Tan","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2025.102493_bib0150","series-title":"Disparities in clinical research and cancer treatment","year":"2024"},{"key":"10.1016\/j.tranon.2025.102493_bib0151","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejca.2022.10.026","article-title":"Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer","volume":"178","author":"Cocks","year":"2023","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.tranon.2025.102493_bib0152","first-page":"297","volume":"38","author":"Merad","year":"2020","journal-title":"Divers. Is Strength Cancer Res. U.S. Cancer Cell"},{"issue":"4","key":"10.1016\/j.tranon.2025.102493_bib0153","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/1948550617708013","article-title":"Mere membership in racially diverse groups reduces conformity","volume":"9","author":"Gaither","year":"2018","journal-title":"Soc Psychol Pers. Sci"},{"issue":"4","key":"10.1016\/j.tranon.2025.102493_bib0154","first-page":"383","article-title":"Diversity improves performance and outcomes","volume":"111","author":"Gomez","year":"2019","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.tranon.2025.102493_bib0155","article-title":"Managing the negative impact of workforce diversity: the important roles of inclusive HRM and employee learning-oriented behaviors","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Psychol."},{"key":"10.1016\/j.tranon.2025.102493_bib0156","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j4366","article-title":"Comparison of postoperative outcomes among patients treated by male and female surgeons: a population based matched cohort study","author":"Wallis","year":"2017","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.tranon.2025.102493_bib0157","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1200\/JOP.2014.001464","article-title":"Diversity by race, Hispanic ethnicity, and sex of the United States medical oncology physician workforce over the past quarter century","volume":"10","author":"Deville","year":"2014","journal-title":"J. Oncol. Pr."},{"issue":"5","key":"10.1016\/j.tranon.2025.102493_bib0158","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.adro.2020.05.003","article-title":"Pathways for recruiting and retaining women and underrepresented minority clinicians and physician scientists into the radiation oncology workforce: a summary of the 2019 ASTRO\/NCI diversity symposium session at the ASTRO annual meeting","volume":"5","author":"Suneja","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102493_bib0159","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ijrobp.2019.01.074","article-title":"Gender, professional experiences, and personal characteristics of academic radiation oncology chairs: data to inform the pipeline for the 21st century","volume":"104","author":"Beeler","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijrobp.2018.08.011","article-title":"Putting women on the escalator: how to address the ongoing leadership disparity in radiation oncology","volume":"103","author":"Knoll","year":"2019","journal-title":"Int. J. Radiat. Oncol.*Biol.*Phys."},{"issue":"6","key":"10.1016\/j.tranon.2025.102493_bib0161","article-title":"Medical students' Socioeconomic status and academic performance in Medical school","volume":"15","author":"Ely","year":"2023","journal-title":"Cureus."},{"issue":"2","key":"10.1016\/j.tranon.2025.102493_bib0162","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1002\/hsr2.264","article-title":"Which disadvantaged students study medicine? Analysis of an English outreach scheme","volume":"4","author":"Murray","year":"2021","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.tranon.2025.102493_bib0163","unstructured":"Association of American Medical Colleges. Diversity in medical education: AAMC facts & figures 2016. [December 23, 2022]; Available from: https:\/\/www.aamcdiversityfactsandfigures2016.org\/."},{"issue":"1","key":"10.1016\/j.tranon.2025.102493_bib0164","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12909-025-06824-5","article-title":"Diversity competence in medical education: short-term effectiveness of an interprofessional diversity-specific undergraduate learning","volume":"25","author":"Linde","year":"2025","journal-title":"BMC. Med. Educ."},{"issue":"12","key":"10.1016\/j.tranon.2025.102493_bib0165","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1089\/jwh.2015.5249","article-title":"A successful strategy to integrate sex and gender medicine into a newly developed medical curriculum","volume":"24","author":"Ludwig","year":"2015","journal-title":"J. Women's Health"},{"issue":"4","key":"10.1016\/j.tranon.2025.102493_bib0166","article-title":"Gender equity in radiation oncology: culture change is a marathon, not a sprint","volume":"7","author":"Schuster","year":"2022","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.tranon.2025.102493_bib0167","unstructured":"American Association for Cancer Research. Overcoming Cancer Health Disparities Through Divers. Cancer Train. Workforce; 2023."},{"issue":"2","key":"10.1016\/j.tranon.2025.102493_bib0168","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.annonc.2021.11.011","article-title":"Investigation of sex and gender differences in oncology gains momentum: ESMO announces the launch of a gender medicine task force","volume":"33","author":"\u00d6zdemir","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tranon.2025.102493_bib0169","unstructured":"Mitgliederversammlung der Helmholtz-Gemeinschaft. Leitlinie der Helmholtz-Gemeinschaft zu Diversit\u00e4t und Inklusion 2020."},{"key":"10.1016\/j.tranon.2025.102493_bib0170","unstructured":"Charta der Vielfalt e.V.|. Diversity Factbook - standpoints, figures, arguments 2021."},{"key":"10.1016\/j.tranon.2025.102493_bib0171","unstructured":"German cancer research center - in the helmholtz association. gender equality, diversity and inclusion plan (GEDIP) 2021 - 2025 2021."},{"key":"10.1016\/j.tranon.2025.102493_bib0172","series-title":"K\u00f6ln","article-title":"Empfehlungen zur Weiterentwicklung der Geschlechterforschung in Deutschland","year":"2023"},{"key":"10.1016\/j.tranon.2025.102493_bib0173","series-title":"Diversity netzwerk \u2013 gelebte Vielfalt an der Charit\u00e9","author":"Berlin","year":"2023"},{"key":"10.1016\/j.tranon.2025.102493_bib0175","series-title":"Best Practices or Best Guesses? Assessing the Efficacy of Corporate Affirmative Action and Diversity Policies - Alexandra Kalev, Frank Dobbin","year":"2006"},{"key":"10.1016\/j.tranon.2025.102493_bib0176","article-title":"Diversified innovations in the health sciences: proposal for a diversity minimal item set (DiMIS)","volume":"33","author":"Stadler","year":"2023","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.tranon.2025.102493_bib0177","article-title":"Increasing diversity, equity, and Inclusion in the health and health services research workforce: a systematic scoping review","author":"Gichane","year":"2024","journal-title":"J. Gen. Intern. Med."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325002244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325002244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T04:54:23Z","timestamp":1765342463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325002244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":176,"alternative-id":["S1936523325002244"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102493","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diversity and inclusivity in oncology: A narrative review and orientation for institutional measures in Germany","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102493"}}